ThuliumV1, Pmc, Corpus, bibRecord, 000271

Plasmakinetic vaporization versus plasmakinetic resection to treat benign prostatic hyperplasia: A prospective randomized trial with 1 year follow-up

Identifieur interne : 000271 ( Pmc/Corpus ); précédent : 000270; suivant : 000272

Plasmakinetic vaporization versus plasmakinetic resection to treat benign prostatic hyperplasia: A prospective randomized trial with 1 year follow-up

Auteurs : Mert Ali Karadag ; Kursat Cecen ; Aslan Demir ; Ramazan Kocaaslan ; Fatih Altunrende

Source :

Canadian Urological Association Journal [ 1911-6470 ] ; 2014.

RBID : PMC:4164545

Abstract

Introduction:

We evaluate the efficacy and outcomes of plasma-kinetic vaporization (PKVP) and plasmakinetic resection (PKR) to treat benign prostatic hyperplasia (BPH).

Methods:

A total of 183 patients with BPH underwent plasma-kinetic prostatic surgery between 2008 and 2012 at Kars State Hospital and Kafkas University Faculty of Medicine, Turkey. After clinical and preoperative evaluation, the patients were randomized to PKRP or PKVP groups sequentially by using computer-generated numbers. Group 1 included 96 patients treated with PKR. Group 2 included 87 patients treated with PKVP. Patients in both groups were compared in terms of hemoglobin drop, operation time, catheter duration, reobstruction, incontinence and recatheterization.

Results:

When we compared the maximum flow rates (Qmax values) at the 12th month, there was no statistical difference between 2 groups. Group 1 had a mean Qmax value of 17.92 ± 3.819 and Group 2 had a 18.15 ± 3.832 value (p > 0.05). There was a statistical difference between the groups in terms of hemoglobin drop, catheter duration and operation time. The mean catheter duration in Group 1 was 3.74 ± 1.049 days, and in Group 2 it was 2.64 ± 0.849 days (p < 0.05). Operation time was statistically longer in Group 2 (PKVP) and hemoglobin drop was statistically higher in Group 1 (PKR).

Conclusion:

PKVP for BPH is safe and effective. When compared with PKRP, it provides a significantly shorter catheter duration and less bleeding due to hemostasis control with similar IPSS and Qmax improvements after 1 year.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164545

DOI: 10.5489/cuaj.1902
PubMed: 25295128
PubMed Central: 4164545

Links to Exploration step

PMC:4164545

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Plasmakinetic vaporization versus plasmakinetic resection to treat benign prostatic hyperplasia: A prospective randomized trial with 1 year follow-up</title>
<author><name sortKey="Karadag, Mert Ali" sort="Karadag, Mert Ali" uniqKey="Karadag M" first="Mert Ali" last="Karadag">Mert Ali Karadag</name>
<affiliation><nlm:aff id="af1-cuaj-9-10-e595">Faculty of Medicine, Department of Urology, Kafkas University, Kars, Turkey;</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Cecen, Kursat" sort="Cecen, Kursat" uniqKey="Cecen K" first="Kursat" last="Cecen">Kursat Cecen</name>
<affiliation><nlm:aff id="af1-cuaj-9-10-e595">Faculty of Medicine, Department of Urology, Kafkas University, Kars, Turkey;</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Demir, Aslan" sort="Demir, Aslan" uniqKey="Demir A" first="Aslan" last="Demir">Aslan Demir</name>
<affiliation><nlm:aff id="af1-cuaj-9-10-e595">Faculty of Medicine, Department of Urology, Kafkas University, Kars, Turkey;</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Kocaaslan, Ramazan" sort="Kocaaslan, Ramazan" uniqKey="Kocaaslan R" first="Ramazan" last="Kocaaslan">Ramazan Kocaaslan</name>
<affiliation><nlm:aff id="af1-cuaj-9-10-e595">Faculty of Medicine, Department of Urology, Kafkas University, Kars, Turkey;</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Altunrende, Fatih" sort="Altunrende, Fatih" uniqKey="Altunrende F" first="Fatih" last="Altunrende">Fatih Altunrende</name>
<affiliation><nlm:aff id="af2-cuaj-9-10-e595">Department of Urology, Istanbul Bilim University, Beşiktaş/İstanbul, Turkey</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">25295128</idno>
<idno type="pmc">4164545</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164545</idno>
<idno type="RBID">PMC:4164545</idno>
<idno type="doi">10.5489/cuaj.1902</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000271</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000271</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Plasmakinetic vaporization versus plasmakinetic resection to treat benign prostatic hyperplasia: A prospective randomized trial with 1 year follow-up</title>
<author><name sortKey="Karadag, Mert Ali" sort="Karadag, Mert Ali" uniqKey="Karadag M" first="Mert Ali" last="Karadag">Mert Ali Karadag</name>
<affiliation><nlm:aff id="af1-cuaj-9-10-e595">Faculty of Medicine, Department of Urology, Kafkas University, Kars, Turkey;</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Cecen, Kursat" sort="Cecen, Kursat" uniqKey="Cecen K" first="Kursat" last="Cecen">Kursat Cecen</name>
<affiliation><nlm:aff id="af1-cuaj-9-10-e595">Faculty of Medicine, Department of Urology, Kafkas University, Kars, Turkey;</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Demir, Aslan" sort="Demir, Aslan" uniqKey="Demir A" first="Aslan" last="Demir">Aslan Demir</name>
<affiliation><nlm:aff id="af1-cuaj-9-10-e595">Faculty of Medicine, Department of Urology, Kafkas University, Kars, Turkey;</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Kocaaslan, Ramazan" sort="Kocaaslan, Ramazan" uniqKey="Kocaaslan R" first="Ramazan" last="Kocaaslan">Ramazan Kocaaslan</name>
<affiliation><nlm:aff id="af1-cuaj-9-10-e595">Faculty of Medicine, Department of Urology, Kafkas University, Kars, Turkey;</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Altunrende, Fatih" sort="Altunrende, Fatih" uniqKey="Altunrende F" first="Fatih" last="Altunrende">Fatih Altunrende</name>
<affiliation><nlm:aff id="af2-cuaj-9-10-e595">Department of Urology, Istanbul Bilim University, Beşiktaş/İstanbul, Turkey</nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Canadian Urological Association Journal</title>
<idno type="ISSN">1911-6470</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec><title>Introduction:</title>
<p>We evaluate the efficacy and outcomes of plasma-kinetic vaporization (PKVP) and plasmakinetic resection (PKR) to treat benign prostatic hyperplasia (BPH).</p>
</sec>
<sec><title>Methods:</title>
<p>A total of 183 patients with BPH underwent plasma-kinetic prostatic surgery between 2008 and 2012 at Kars State Hospital and Kafkas University Faculty of Medicine, Turkey. After clinical and preoperative evaluation, the patients were randomized to PKRP or PKVP groups sequentially by using computer-generated numbers. Group 1 included 96 patients treated with PKR. Group 2 included 87 patients treated with PKVP. Patients in both groups were compared in terms of hemoglobin drop, operation time, catheter duration, reobstruction, incontinence and recatheterization.</p>
</sec>
<sec><title>Results:</title>
<p>When we compared the maximum flow rates (Qmax values) at the 12th month, there was no statistical difference between 2 groups. Group 1 had a mean Qmax value of 17.92 ± 3.819 and Group 2 had a 18.15 ± 3.832 value (<italic>p</italic>
 > 0.05). There was a statistical difference between the groups in terms of hemoglobin drop, catheter duration and operation time. The mean catheter duration in Group 1 was 3.74 ± 1.049 days, and in Group 2 it was 2.64 ± 0.849 days (<italic>p</italic>
 < 0.05). Operation time was statistically longer in Group 2 (PKVP) and hemoglobin drop was statistically higher in Group 1 (PKR).</p>
</sec>
<sec><title>Conclusion:</title>
<p>PKVP for BPH is safe and effective. When compared with PKRP, it provides a significantly shorter catheter duration and less bleeding due to hemostasis control with similar IPSS and Qmax improvements after 1 year.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Can Urol Assoc J</journal-id>
<journal-id journal-id-type="iso-abbrev">Can Urol Assoc J</journal-id>
<journal-id journal-id-type="publisher-id">CUAJ</journal-id>
<journal-title-group><journal-title>Canadian Urological Association Journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">1911-6470</issn>
<publisher><publisher-name>Canadian Medical Association</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">25295128</article-id>
<article-id pub-id-type="pmc">4164545</article-id>
<article-id pub-id-type="doi">10.5489/cuaj.1902</article-id>
<article-id pub-id-type="publisher-id">cuaj-9-10-e595</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group><article-title>Plasmakinetic vaporization versus plasmakinetic resection to treat benign prostatic hyperplasia: A prospective randomized trial with 1 year follow-up</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Karadag</surname>
<given-names>Mert Ali</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="af1-cuaj-9-10-e595"><sup>*</sup>
</xref>
<xref rid="c1-cuaj-9-10-e595" ref-type="corresp"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Cecen</surname>
<given-names>Kursat</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="af1-cuaj-9-10-e595"><sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Demir</surname>
<given-names>Aslan</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="af1-cuaj-9-10-e595"><sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Kocaaslan</surname>
<given-names>Ramazan</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="af1-cuaj-9-10-e595"><sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Altunrende</surname>
<given-names>Fatih</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="af2-cuaj-9-10-e595"><sup>†</sup>
</xref>
</contrib>
<aff id="af1-cuaj-9-10-e595"><label>*</label>
Faculty of Medicine, Department of Urology, Kafkas University, Kars, Turkey;</aff>
</contrib-group>
<aff id="af2-cuaj-9-10-e595"><label>†</label>
Department of Urology, Istanbul Bilim University, Beşiktaş/İstanbul, Turkey</aff>
<author-notes><corresp id="c1-cuaj-9-10-e595">Correspondence: Dr. Mert Ali Karadag, Faculty of Medicine, Department of Urology, Kafkas University, Kars, Turkey; <email>karadagmert@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub"><season>Sep-Oct</season>
<year>2014</year>
</pub-date>
<pub-date pub-type="epub"><day>09</day>
<month>9</month>
<year>2014</year>
</pub-date>
<volume>8</volume>
<issue>9-10</issue>
<fpage>E595</fpage>
<lpage>E599</lpage>
<permissions><copyright-statement>Copyright: © 2014 Canadian Urological Association or its licensors</copyright-statement>
<copyright-year>2014</copyright-year>
</permissions>
<abstract><sec><title>Introduction:</title>
<p>We evaluate the efficacy and outcomes of plasma-kinetic vaporization (PKVP) and plasmakinetic resection (PKR) to treat benign prostatic hyperplasia (BPH).</p>
</sec>
<sec><title>Methods:</title>
<p>A total of 183 patients with BPH underwent plasma-kinetic prostatic surgery between 2008 and 2012 at Kars State Hospital and Kafkas University Faculty of Medicine, Turkey. After clinical and preoperative evaluation, the patients were randomized to PKRP or PKVP groups sequentially by using computer-generated numbers. Group 1 included 96 patients treated with PKR. Group 2 included 87 patients treated with PKVP. Patients in both groups were compared in terms of hemoglobin drop, operation time, catheter duration, reobstruction, incontinence and recatheterization.</p>
</sec>
<sec><title>Results:</title>
<p>When we compared the maximum flow rates (Qmax values) at the 12th month, there was no statistical difference between 2 groups. Group 1 had a mean Qmax value of 17.92 ± 3.819 and Group 2 had a 18.15 ± 3.832 value (<italic>p</italic>
 > 0.05). There was a statistical difference between the groups in terms of hemoglobin drop, catheter duration and operation time. The mean catheter duration in Group 1 was 3.74 ± 1.049 days, and in Group 2 it was 2.64 ± 0.849 days (<italic>p</italic>
 < 0.05). Operation time was statistically longer in Group 2 (PKVP) and hemoglobin drop was statistically higher in Group 1 (PKR).</p>
</sec>
<sec><title>Conclusion:</title>
<p>PKVP for BPH is safe and effective. When compared with PKRP, it provides a significantly shorter catheter duration and less bleeding due to hemostasis control with similar IPSS and Qmax improvements after 1 year.</p>
</sec>
</abstract>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/Pmc/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000271 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000271 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Terre
   |area=    ThuliumV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:4164545
   |texte=   Plasmakinetic vaporization versus plasmakinetic resection to treat benign prostatic hyperplasia: A prospective randomized trial with 1 year follow-up
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:25295128" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a ThuliumV1

This area was generated with Dilib version V0.6.21.
Data generation: Thu May 12 08:27:09 2016. Site generation: Thu Mar 7 22:33:44 2024

	Serveur d'exploration sur le thulium
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le thulium

Plasmakinetic vaporization versus plasmakinetic resection to treat benign prostatic hyperplasia: A prospective randomized trial with 1 year follow-up

Plasmakinetic vaporization versus plasmakinetic resection to treat benign prostatic hyperplasia: A prospective randomized trial with 1 year follow-up

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki